Integrating the dual roles of SLC7A11 in ferroptosis regulation and thyroid cancer progression, we hypothesize that combining SAS with 131I may synergistically enhance treatment efficacy through concerted SLC7A11 inhibition. This evidence concerns the gene SLC7A11 and thyroid cancer.